Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma

被引：0
|
作者：
Cerchione, Claudio
Catalano, Lucio
Nappi, Davide
Musuraca, Gerardo
Lucchesi, Alessandro
Pane, Fabrizio
Martinelli, Giovanni
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-143189
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Catalano, L.
    Nappi, D.
    Musuraca, G.
    Lucchesi, A.
    Pareto, A. E.
    Di Perna, M.
    Ferrara, K.
    Ronconi, S.
    Ceccolini, M.
    Cangini, D.
    Giannini, M. B.
    Di Battista, V.
    Simonetti, G.
    Ferrari, A.
    Bochicchio, M. T.
    di Rora, A. Ghelli Luserna
    Ghetti, M.
    Napolitano, R.
    Fontana, M. C.
    Padella, A.
    Pane, F.
    Martinelli, G.
    HAEMATOLOGICA, 2020, 105 : S104 - S104
  • [2] Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
    Cerchione, Claudio
    Ferrara, Katia
    Peluso, Ilaria
    Di Perna, Maria
    Nappi, Davide
    Pareto, Anna Emanuele
    Pane, Fabrizio
    Catalano, Lucio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S255 - S255
  • [3] CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Martinelli, G.
    Nappi, D.
    Pareto, A. E.
    Di Perna, M.
    Ferrara, K.
    Musuraca, G.
    Lucchesi, A.
    Ferrari, A.
    Simonetti, G.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2019, 104 : 71 - 71
  • [4] Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
    Cerchione, Claudio
    Catalano, Lucio
    Nappi, Davide
    Pareto, Anna Emanuele
    Musuraca, Gerardo
    Lucchesi, Alessandro
    Pane, Fabrizio
    Martinelli, Giovanni
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S310 - S310
  • [5] Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
    Cerchione, Claudio
    Martinelli, Giovanni
    Catalano, Lucio
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 : S5 - S6
  • [6] Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
    Cerchione, Claudio
    Martinelli, Giovanni
    Nappi, Davide
    Pareto, Anna Emanuele
    Di Perna, Maria
    Ronconi, Sonia
    Pane, Fabrizio
    Catalano, Lucio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E358 - E359
  • [7] Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
    Cerchione, Claudio
    Nappi, Davide
    Pareto, Anna Emanuele
    Pane, Fabrizio
    Catalano, Lucio
    Martinelli, Giovanni
    BLOOD, 2021, 138
  • [8] CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Ferrara, K.
    Peluso, I.
    Di Perna, M.
    Zacheo, I.
    Nappi, D.
    Pareto, A. E.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2018, 103 : S85 - S85
  • [9] Carfilzomib-lenalidomide-dexamethasone in the management of lenalidomide-refractory multiple myeloma.
    Cerchione, Claudio
    Martinelli, Giovanni
    Nappi, Davide
    Pareto, Anna Emanuele
    Di Perna, Maria
    Ferrara, Katia
    Pane, Fabrizio
    Catalano, Lucio
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA: A REAL-LIFE EXPERIENCE
    Cerchione, C.
    Ferrara, K.
    Peluso, I
    Di Perna, M.
    Zacheo, I
    Nappi, D.
    Pareto, A. E.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2018, 103 : 39 - 39
12345